Substrate specificity and the effect of calcium on Trypanosomabrucei metacaspase 2 by Machado, M.K.M et al.
  
 
 
 
 
Machado, M.K.M, Marcondes, M.F., Juliano, M.A., McLuskey, K., 
Mottram, J.C., Moss, C.X., Juliano, L., and Oliveira, V. (2013) Substrate 
specificity and the effect of calcium on Trypanosomabrucei metacaspase 2. 
FEBS Journal, 280 (11). pp. 2608-2621. ISSN 1742-464X 
 
 
Copyright © 2013 The Authors  
 
 
A copy can be downloaded for personal non-commercial research or 
study, without prior permission or charge 
 
Content must not be changed in any way or reproduced in any format 
or medium without the formal permission of the copyright holder(s) 
 
 
When referring to this work, full bibliographic details must be given 
 
 
 
http://eprints.gla.ac.uk/81541 
 
 
Deposited on: 01 July 2013 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk 
Substrate specificity and the effect of calcium
on Trypanosoma brucei metacaspase 2
Maurıcio F. M. Machado1, Marcelo F. Marcondes1, Maria A. Juliano1, Karen McLuskey2,
Jeremy C. Mottram2, Catherine X. Moss2, Luiz Juliano1 and Vitor Oliveira1
1 Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de S~ao Paulo, Brazil
2 Wellcome Trust Centre for Molecular Parasitology, Institute of Infection Immunity and Inflammation, College of Medical Veterinary and
Life Sciences, University of Glasgow, UK
Keywords
calcium binding; kinetic parameters;
metacaspase; structural modification;
substrate specificity
Correspondence
V. Oliveira, Departamento de Biofısica,
Laboratorio de Enzimologia, Universidade
Federal de S~ao Paulo, Rua Pedro de Toledo,
669 – 7 andar, S~ao Paulo 04039-032, SP,
Brazil
Fax: +55 11 55759617
Tel: +55 11 55764450 ext 1966
E-mail: vitor.oliveira@unifesp.br
(Received 30 November 2012, revised 19
February 2013, accepted 11 March 2013)
doi:10.1111/febs.12248
Metacaspases are cysteine peptidases found only in yeast, plants and lower
eukaryotes, including the protozoa. To investigate the extended substrate
specificity and effects of Ca2+ on the activation of these enzymes, detailed
kinetic, biochemical and structural analyses were carried out on metacas-
pase 2 from Trypanosoma brucei (TbMCA2). These results reveal that
TbMCA2 has an unambiguous preference for basic amino acids at the P1
position of peptide substrates and that this is most probably a result of
hydrogen bonding from the P1 residue to Asp95 and Asp211 in TbMCA2.
In addition, TbMCA2 also has a preference for charged residues at the P2
and P3 positions and for small residues at the prime side of a peptide sub-
strate. Studies into the effects of Ca2+ on the enzyme revealed the presence
of two Ca2+ binding sites and a reversible structural modification of the
enzyme upon Ca2+ binding. In addition, the concentration of Ca2+ used
for activation of TbMCA2 was found to produce a differential effect on
the activity of TbMCA2, but only when a series of peptides that differed in
P2 were examined, suggesting that Ca
2+ activation of TbMCA2 has a
structural effect on the enzyme in the vicinity of the S2 binding pocket.
Collectively, these data give new insights into the substrate specificity and
Ca2+ activation of TbMCA2. This provides important functional details
and leads to a better understanding of metacaspases, which are known to
play an important role in trypanosomes and make attractive drug targets
due to their absence in humans.
Introduction
Metacaspases are cysteine peptidases that are distantly
related to the mammalian caspases but found only in
plants, fungi and protozoa [1]. Together with the casp-
ases and paracaspases [1], they are endopeptidases
which have been grouped into structural family C14 in
clan CD of the MEROPS peptidase database [2]. In Try-
panosoma brucei, five metacaspase genes (TbMCA1–5)
have been reported with three, TbMCA2, TbMCA3
and TbMCA5, predicted to code for active peptidases
based on the conservation of an intact cysteine-histi-
dine catalytic dyad [3,4]. Interestingly, in TbMCA1
and TbMCA4 the catalytic cysteine is replaced by a
serine, indicating that the coded proteins would not
exhibit cysteine peptidase activity [3,5]. Whilst plant
metacaspases have been shown to be involved in cell
death pathways, trypanosomes appear to lack regu-
lated cell death [6] and in these organisms metacaspas-
es have evolved alternative functions [5,7].
Abbreviations
Abz, ortho-aminobenzoic acid; EDDnp, N-(2,4-dinitrophenyl)-ethylenediamine; FRET, fluorescence resonance energy transfer;
TbMCA2, Trypanosoma brucei metacaspase 2.
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Despite being related to the caspases, metacaspases
have been shown to be both structurally and function-
ally distinct. Metacaspases are known to cleave their
substrates after Arg and Lys residues in the P1 posi-
tion [8], as demonstrated for metacaspases from Trypa-
nosoma brucei [9], Trypanosoma cruzi [10], Leishmania
major [11], plants [12–14] and yeast [13], while the
caspases cleave their substrates after Asp [15]. Other
functional differences between the two families of
enzymes are that, unlike the caspases, metacaspases do
not necessarily require processing or dimerization for
activity and they are activated by calcium [9,12–14,16].
In addition, the recent crystallographic structures of
TbMCA2 and the Saccharomyces cerevisiae metacas-
pase (YCA1) [17,18] provided a structural basis for
comparing caspases and metacaspases. The metacas-
pase structures revealed a monomeric enzyme con-
taining a core caspase/haemoglobinase fold [19] with
an eight-stranded b-sheet consisting of six parallel
and two anti-parallel strands. This is unlike the
caspases, which comprise a six-stranded b-sheet and
a stable dimerization interface which forms the
active enzyme. In addition, the recent structure of a
paracaspase [20] shows that it is structurally very
similar to the caspases and dimerizes in a similar
manner. Conversely, the two extra strands in the
b-sheet of the metacaspases prevent such dimeriza-
tion, explaining its monomeric peptidase activity and
distinguishing the metacaspases structurally from
other caspase family members.
The high resolution crystal structure of TbMCA2 was
determined using inactive mutants (TbMCA2 C213A/G),
as autoprocessing of the full-length recombinant
enzyme in vitro was unfavourable for producing dif-
fraction quality crystals [17,18]. This revealed an unu-
sual N-terminal region, which encircled the protein
and crossed over the active site, blocking the S1 pocket.
Consequently, the structure of TbMCA2 does not
contain an active site substrate and the properties of its
extended binding site have not yet been established.
In this study, we undertook to examine the extended
substrate specificity of recombinant and active
TbMCA2 using a series of fluorescence resonance
energy transfer (FRET) peptides. The specificity of
TbMCA2 subsites S3 to S3′ were analysed by kinetic
assays that monitored the hydrolysis of a FRET pep-
tide series where positions P3 to P′3 on the peptides
are substituted by each of the natural amino acids. In
addition, the effects of Ca2+ on the structure, activity
and extended subsite specificity of TbMCA2 were
investigated using a series of kinetic assays, intrinsic
fluorescence analysis and circular dichroism spectro-
scopy.
Results
Effects of temperature, pH and Ca2+
concentration on the activity of TbMCA2
The activity of TbMCA2 was initially assayed using
the reference substrate Abz-KARSSAQ-EDDnp over a
range of temperatures (20–37 °C), pH values (pH 5 to
pH 11) and CaCl2 concentrations (0–5 mM).
Aliquots of TbMCA2 were incubated in the pres-
ence of Ca2+ at four different temperatures (20, 25, 30
and 37 °C) for 15 min and the residual activity was
measured at 2.5 min and then at 5 min intervals show-
ing that the remaining activity of TbMCA2 decreases
most rapidly at higher temperatures (Fig. 1). At higher
temperatures TbMCA2 undergoes much more exten-
sive autoprocessing, as observed by SDS/PAGE analy-
sis (data not shown), suggesting that while minimal
autoprocessing is not detrimental [9], unlimited auto-
processing will ultimately inactivate TbMCA2. It was
also noted that TbMCA2 is stable at 37 °C for at least
60 min when incubated in the presence of a saturating
substrate concentration (data not shown). However, in
order to reduce TbMCA2 activity loss during the reac-
tions all assays were conducted at 25 °C.
The relationship between pH and kcat/KM, for the
hydrolysis of Abz-KARSSAQ-EDDnp by TbMCA2,
indicates an optimum pH for TbMCA2 activity of 7.7
and the participation of two ionizing groups with
pKe1 = 6.70  0.02 and pKe2 = 8.70  0.02, which can
be directly attributed to the histidine (pKa 6.7)–cysteine
(pKa 8.7) catalytic dyad (Fig. 2). This bell-shaped pH
profile and the calculated pK values are similar to those
Fig. 1. The thermal stability of TbMCA2. The activity of TbMCA2
was measured over a 15-min period using time intervals of between
2.5 and 5 min at 37 °C (□), 30 °C (■), 25 °C (○) and 20 °C (●).
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observed for caspases [21,22] indicating that TbMCA2
shares a similar pH dependence and signifies the exis-
tence of one active form of the enzyme with the
increase in activity most probably a result of the
de-protonation of the catalytic cysteine [22]. Such inter-
pretation is supported by previous site directed muta-
genesis studies [9] and more recently by the analysis of
the crystallographic structure of TbMCA2 where the
position of the Cys213Ala and His158 catalytic dyad
was shown to be conserved with the caspases [17].
To investigate the effect of Ca2+ on the activity of
TbMCA2, the kinetic parameters for the hydrolysis of
Abz-KARSSAQ-EDDnp were calculated using CaCl2
concentrations in the range 0–5 mM. Both kcat and
kcat/KM were found to increase sharply up to ~ 500 lM
of CaCl2 but above this concentration both kcat and
kcat/KM started to decrease (Fig. 3A,B). KM increases
with CaCl2 concentration up to 1 mM and reaches a
plateau above this CaCl2 concentration (Fig. 3C). The
fact that high CaCl2 concentrations affect TbMCA2
efficiency and turnover but not substrate affinity sug-
gests that, at high concentrations, CaCl2 does not alter
the substrate binding site.
TbMCA2 substrate specificity
The substrate specificity of TbMCA2 was studied
using six individual series of FRET peptides derived
from Abz-KARSSA-Q-EDDnp (Table 1). This peptide
was chosen from a series of fluorogenic peptidase sub-
strates that we had available in our laboratory and
was modified in order to provide a simple and appro-
priate reference peptide for our work with TbMCA2.
The peptides were synthesized by substituting a single
amino acid residue in the Lys-Ala-Arg-Ser-Ser-Ala
(KARSSA) portion of the substrate by all of the natu-
ral amino acids (with exception of Cys and Trp) at
positions P3 to P′3, with the Arg-Ser (R↓S) bond being
the cleavage site unless otherwise indicated. Where
peptide synthesis was successful, the peptides were
assayed and the resulting kinetic constants are shown
in Table 1. In addition, the products of hydrolysis of
the cleaved peptides were analysed by HPLC coupled
to an ion spray mass spectrometer in order to verify
the cleavage site(s) in each substrate.
P1 residue: hydrolysis of the Abz-KAXSSAQ-EDDnp
series
The substrates with basic residues (X = Arg or Lys) in
P1 were the only peptides to be hydrolysed by
TbMCA2 in this series and the cleavage was exclu-
sively at peptide bond Arg-Ser and Lys-Ser, with a
clear preference for the peptide containing Arg at the
P1 position. All other peptides tested were resistant to
cleavage. These results confirm the previously
described substrate specificity of TbMCA2 [9] and of
other metacaspases [8,13,23]. Peptides in the series that
Fig. 2. The pH dependence of TbMCA2. The profile of kcat/KM for
TbMCA2 hydrolysis of Abz-KARSSAQ-EDDnp indicates an optimum
pH for activity of 7.7 and the participation of two ionizing groups
with pKe1 ~ 6.70 and pKe2 ~ 8.70.
A B C
Fig. 3. Activity of TbMCA2 measured over a range of CaCl2 concentrations. Kinetic parameters for the hydrolysis of Abz-KARSSAQ-EDDnp
by TbMCA2 were calculated for kcat/KM (A), kcat (B) and KM (C).
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Table 1. Kinetic parameters for the hydrolysis of FRET peptides derived from Abz-KARSSAQ-EDDnp by TbMCA2. An asterisk indicates the
peptides that present substrate inhibition. The substrate inhibition parameters were calculated using Eqn (1). KM, kcat and kcat/KM are given
here but the substrate inhibition constants (KiA) are in the text. A dash represents peptides that were not assayed.
Parameters P3 (K) P2 (A) P1 (R) P ′1 (S) P′2 (S) P′3 (A)
R KM (lM) 0.37  0.03 0.19  0.01 0.29  0.03 Cleavages R↓R
and R↓S
Cleavage R↓S
and R↓A
Cleavage R↓S
and R↓Q
kcat (s
1) 0.500  0.003 0.400  0.005 0.600  0.009
kcat/KM (mM
1s1) 1351 2105 2068
K KM (lM) 0.29  0.03 0.29  0.02 0.49  0.02 Cleavage R↓K
and K↓S
Cleavage R↓S
and K↓A
Cleavage R↓S
and K↓Q
kcat (s
1) 0.600  0.009 1.80  0.03 0.300  0.005
kcat/KM (mM
1s1) 2068 6206 612
G KM (lM) – 0.74  0.08 2.2  0.2 1.51  0.06 0.30  0.02
kcat (s
1) – 0.300  0.008 Resistant 0.100  0.004 1.60  0.02 0.100  0.001
kcat/KM (mM
1s1) – 405 Ki = 17 lM 45 1059 333
A KM (lM) – 0.29  0.03 0.87  0.07 – 0.29  0.03
kcat (s
1) – 0.600  0.009 Resistant 0.500  0.009 – 0.600  0.009
kcat/KM (mM
1s1) – 2068 Ki = 7.5 lM 574 – 2068
L KM (lM) 0.85  0.06 0.49  0.06 1.4  0.7 – –
kcat (s
1) 0.300  0.006 0.300  0.007 Resistant 0.080  0.004 – –
kcat/KM (mM
1s1) 352 612 Ki = 9.4 lM 57 – –
I KM (lM) – 0.56  0.06 0.12  0.01 3.2*  0.3
kcat (s
1) – 0.0500  0.0001 Resistant Resistant 0.80  0.01 2.9*  0.1
kcat/KM (mM
1s1) – 89 Ki = 4.8 lM Ki = 7.8 lM 6666 906*
V KM (lM) 1.2  0.1 1.2  0.1 0.53  0.04 0.36  0.02 1.0  0.1
kcat (s
1) 0.200  0.003 0.40  0.01 Resistant 0.050  0.001 0.500  0.007 1.90  0.05
kcat/KM (mM
1s1) 167 333 Ki = 8.4 lM 94 1388 1900
M KM (lM) 0.61  0.04 0.2  0.1 0.96  0.02 – 0.36  0.03
kcat (s
1) 0.200  0.002 0.100  0.003 Resistant 0.200  0.005 – 0.400  0.008
kcat/KM (mM
1s1) 327 500 Ki = 12.4 lM 208 – 1111
P KM (lM) – 0.83  0.07 0.45  0.04* 1.0  0.1
kcat (s
1) – 0.400  0.009 Resistant Resistant 0.100  0.005* 0.300  0.008
kcat/KM (mM
1s1) – 481 Ki = 9.4 lM Ki = 4.6 lM 222* 300
F KM (lM) 0.33  0.03 0.22*  0.01 0.64*  0.06
kcat (s
1) 0.100  0.002 0.20*  0.01 Resistant Resistant Resistant 6.0*  0.3
kcat/KM (mM
1s1) 303 909* Ki = 4.2 lM Ki = 3.9 lM Ki = 9.6 lM 9375*
Y KM (lM) – 0.22*  0.01 0.35  0.03
kcat (s
1) – 0.30*  0.01 Resistant Resistant Resistant 0.70  0.02
kcat/KM (mM
1s1) – 1363* Ki = 3.8 lM Ki = 4.1 lM Ki = 6.7 lM 2000
H KM (lM) 1.22  0.01 0.72  0.07 1.70  0.06 0.29  0.02 0.59  0.04
kcat (s
1) 0.600  0.002 0.300  0.008 Resistant 0.300  0.003 0.100  0.005 0.80  0.01
kcat/KM (mM
1s1) 491 417 Ki = 5.1 lM 176 344 1355
N KM (lM) 2.1  0.3 0.46  0.03 1.6  0.1 – 1.1  0.1
kcat (s
1) 0.100  0.004 0.400  0.007 Resistant 0.40  0.01 – 0.30  0.01
kcat/KM (mM
1s1) 48 869 Ki = 6.7 lM 250 – 272
Q KM (lM) – 3.4  0.2 1.38  0.03 0.71  0.04 0.50  0.03
kcat (s
1) – 0.90  0.02 Resistant 0.300  0.001 0.100  0.001 0.200  0.003
kcat/KM (mM
1s1) – 265 Ki = 5.7 lM 217 140 400
S KM (lM) – 0.51  0.05 0.29  0.03 0.29  0.03 1.6  0.1
kcat (s
1) – 0.200  0.004 Resistant 0.600  0.009 0.600  0.009 0.80  0.01
kcat/KM (mM
1s1) – 392 Ki = 7.8 lM 2068 2068 500
T KM (lM) 2.5  0.2 1.0  0.1 1.03  0.06 – 1.9  0.2
kcat (s
1) 0.200  0.001 0.40  0.02 Resistant 0.400  0.005 – 0.20  0.01
kcat/KM (mM
1s1) 167 400 Ki = 9.4 lM 388 – 105
D KM (lM) 11.9  1.7 2.9  0.1 0.52  0.05 4.0  0.3
kcat (s
1) Resistant 0.100  0.005 Resistant 0.100  0.005 0.080  0.001 0.40  0.01
kcat/KM (mM
1s1) Ki = 4.2 lM 8 Ki = 2.9 lM 34 153 100
E KM (lM) 2.1  0.3 0.25  0.04 0.44  0.05
kcat (s
1) Resistant Resistant Resistant 0.100  0.005 0.60  0.02 0.040  0.001
kcat/KM (mM
1s1) Ki = 3.8 lM Ki = 7.8 lM Ki = 3.5 lM 48 2400 90
FEBS Journal 280 (2013) 2608–2621 ª 2013 The Authors Journal compilation ª 2013 FEBS 2611
M. F. M. Machado et al. TbMCA2 substrate specificity and Ca2+ activation
were found to be resistant to hydrolysis by TbMCA2
(where X 6¼ Arg or Lys) were all assayed as inhibitors
and found to be competitive inhibitors, for which the
Ki values are shown in Table 1. It should be noted
that lower Ki values were obtained with Abz-KADS-
SAQ-EDDnp or Abz-KAESSAQ-EDDnp, indicating
that the negatively charged side chain of Asp or Glu
interacted with TbMCA2 in an unusual inhibitory
manner, such as through allostery.
P2 residue: hydrolysis of the Abz-KXRSSAQ-EDDnp
series
Peptides containing basic amino acids Arg or Lys
showed the highest specificity constants in this series
(kcat/KM = 6200 mM
1s1 and 2100 mM1s1, respec-
tively), although the substrate containing an Ala sub-
stitution was also efficiently hydrolysed by TbMCA2
with kcat/KM = 2100 mM
1s1. Peptides containing
aromatic residues (Phe and Tyr) were also efficiently
hydrolysed with kcat/KM = 1400 mM
1s1 and 900
mM1s1, respectively, but these FRET peptides
exhibited substrate inhibition at concentrations higher
than 10 lM and the observed KiA constants determined
for the unproductive binding were 14.7 lM (Tyr) and
27.1 lM (Phe). The peptide that contained Asp at the
P2 position had the lowest kcat/KM value (8 mM
1s1)
and highest KM (12 lM) and the peptide Abz-KER-
SSAQ-EDDnp was resistant to hydrolysis; thus a neg-
atively charged group at the P2 position of the
substrates is very unfavourable for TbMCA2 activity.
P3 residue: hydrolysis of the Abz-XARSSAQ-EDDnp
series
Of the peptides tested in this series, the substrates con-
taining basic residues Arg or Lys at the P3 position
were the most susceptible to hydrolysis by TbMCA2.
Together with the results for the P2 series, this suggests
a preference of TbMCA2 non-prime sites for positively
charged basic residues. In accordance with this obser-
vation, the peptides containing Glu and Asp were
resistant to hydrolysis but inhibited the enzyme with a
Ki of around 4 lM. All the other peptides tested in this
series were hydrolysed but with low kcat/KM.
P′1 residue: hydrolysis of the Abz-KARXSAQ-EDDnp
series
All the peptides in this series susceptible to hydrolysis
were cleaved at the Arg-X peptide bond except for the
substrates where X = Arg or Lys; these substrates
were also hydrolysed by TbMCA2 at the Arg-Arg (or
Arg-Lys) (60%) and Arg-Ser (or Lys-Ser) (40%) posi-
tions. The kinetic parameters for peptides hydrolysed
at more than one position were not calculated. The ref-
erence peptide with Ser at the P′1 position was the most
susceptible substrate to hydrolysis by TbMCA2 (kcat/
KM = 2100 mM
1s1), while peptides containing ali-
phatic residues were poorly hydrolysed or even resistant
to hydrolysis (Pro and Ile). In addition, TbMCA2 did
not cleave peptides containing the aromatic residues
Phe and Tyr at this position, and those with negatively
charged side chains (Asp and Glu) were poorly hydro-
lysed. These results suggest that the S′1 binding pocket
has a preference for residues with small side chains.
P′2 residue: hydrolysis of the Abz-KARSXAQ-EDDnp
series
Of the substrates tested in this series, the one that was
most susceptible to hydrolysis by TbMCA2 was the
peptide containing Ile at the P′2 position. The peptide
containing Glu at this position was also well hydroly-
sed by TbMCA2, with kcat/KM = 2400 mM
1s1; how-
ever, this contrasts sharply with the low hydrolysis
observed when an Asp is present in P′2 (kcat/
KM = 153 mM
1s1). The substrate containing Pro in
P′2 presented substrate inhibition and the estimated
inhibition constant for this unproductive enzyme–sub-
strate interaction is KiA = 5.9 lM. In addition, peptides
with Ser, Gly or Val at this position were hydrolysed
with relatively high kcat/KM values, whereas peptides
with the aromatic residues Tyr and Phe were resistant
to hydrolysis.
P′3 residue: hydrolysis of the Abz-KARSSXQ-EDDnp
series
In this series, the peptide containing Phe at the P′3
position showed the highest kcat/KM (9375 mM
1s1)
amongst all of the assayed peptides, mainly due to the
high value of kcat (6.0 s
1), but this substrate also
showed substrate inhibition kinetics with KiA = 3.7 lM.
TbMCA2 also efficiently hydrolysed the peptide con-
taining Tyr at the P′3 position; however, this happened
without substrate inhibition. Peptides with Ala, Ile,
His and Met were also efficiently hydrolysed by
TbMCA2 (kcat/KM  900) with the peptide contain-
ing Ile also displaying substrate inhibition (KiA =
0.5 lM).
Influence of CaCl2 on TbMCA2
The effects of Ca2+ on the activity of TbMCA2 were
further investigated using the fluorogenic peptides
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Z-RR-AMC and Z-FR-AMC, which are both hydroly-
sed at Arg↓AMC. Different profiles of activation were
observed for these two substrates: the hydrolysis of
Z-RR-AMC produced a kcat/KM that significantly
increased up to a concentration of 250 lM CaCl2 and
then decreased at higher concentrations, whereas the
kcat/KM values of Z-FR-AMC increased until around
6 mM CaCl2 and declined after this (to the measured
20 mM) (Fig. 4A). As these two peptides differ only at
the P2 position, the influence of this residue on the
activation of TbMCA2 by Ca2+ was further explored.
Initially, the FRET peptides Abz-KRR↓SSAQ-ED-
Dnp, Abz-KFR↓SSAQ-EDDnp and Abz-KAR↓SSAQ-
EDDnp were assayed over a range of Ca2+ concentra-
tions (0–5 mM) and the activation profiles for the
hydrolysis of these longer peptides were found to be
similar to those observed with Z-RR-AMC and Z-FR-
AMC (Fig. 4B). This confirmed that the P2 residue
had an effect on the activation of TbMCA2 by Ca2+.
To confirm these results the effect of Ca2+ concen-
tration on the kinetic behaviour of TbMCA2 was
tested with all substrates presented in Table 1. Kinetic
assays were carried out with TbMCA2 using the series
of peptides at low (50 lM) and high (1 mM) Ca2+
concentrations but only substrates with residues that
varied in P2 (P2-varying substrates, Abz-KXRSSAQ-
EDDnp) presented a differential Ca2+ effect as repre-
sented in Fig. 5 and Table 2. Analysing the results
from these assays revealed that the P2-varying
substrates could be split into three distinct groups:
A B
Fig. 4. The influence of CaCl2 on TbMCA2
activity. (A) The effect of CaCl2 on kcat/KM
for the hydrolysis of Z-FR↓-AMC (●) and Z-
RR↓-AMC (○) by TbMCA2. (B) The effect
of CaCl2 on kcat/KM for the hydrolysis of
Abz-KAR↓SSAQ-EDDnp (■), Abz-
KRR↓SSAQ-EDDnp (□) and Abz-
KFR↓SSAQ-EDDnp (△) by TbMCA2.
A C E
B D F
Fig. 5. Differential effect of calcium activation for substrates varying at the P2 position. The hydrolysis rate of reaction versus substrate
concentration was plotted in the presence of 50 lM (low) and 1 mM (high) CaCl2 for FRET substrates that differed in the P2 position. The
representative substrates shown are Abz-KAR↓SSAQ-EDDnp [P2 = Ala, (A) and (B)]; Abz-KLR↓SSAQ-EDDnp [P2 = Leu, (C) and (D)] and Abz-
KYR↓SSAQ-EDDnp [P2 = Tyr, (E) and (F)].
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substrates that show no inhibition regardless of the
Ca2+ concentration (Ala, Thr and Gly); substrates
that show inhibition at low (50 lM) but not high
(1 mM) Ca2+ concentrations (Leu, Ile and Gln); and
substrates that inhibit TbMCA2 regardless of the
Ca2+ concentration (Tyr and Phe). These differential
Ca2+ effects are exemplified using a representative
substrate from each group (Ala, Leu and Tyr) by plot-
ting substrate hydrolysis velocity (V) versus substrate
concentration [S] at both low (50 lM) and high (1 mM)
Ca2+ concentrations and by calculating the substrate
inhibition constants KiA over a range of Ca
2+ concen-
trations (Fig. 5 and Table 2, respectively).
Kinetic assays using substrates represented by Ala
at the P2 position produced hyperbolic plots at both
low (50 lM) and high (1 mM) Ca2+ concentrations
(Fig. 5A,B) and showed no substrate inhibition
(Table 2). However, for peptides represented by Leu in
P2, the kinetics for hydrolysis presented substrate inhi-
bition at low Ca2+ concentration (50 lM) which was
completely abolished in assays performed in the pres-
ence of a high concentration of Ca2+ (1 mM) (Fig. 5C,
D). This effect was shown to be gradual, with the KiA
values rising with increasing Ca2+ concentration until
around 0.5 mM after which substrate inhibition was
abolished (Table 2). Additionally, kinetic assays per-
formed with peptides represented by Tyr in P2 showed
that excess substrate inhibition kinetics were observed
independent of the Ca2+ concentration, as shown in
Fig. 5E,F and Table 2.
Examining Ca2+ binding in TbMCA2
It has been shown previously that the addition of
Ca2+ to TbMCA2 activates the enzyme and leads to
autoprocessing events [9]. To better understand how
Ca2+ might activate TbMCA2, we analysed TbMCA2
using far-UV circular dichroism spectra and intrinsic
fluorescence assays (Fig. 6). Prior to analysis, a sample
of TbMCA2 was treated with 1 mM CaCl2 and
Table 2. Substrate inhibition constants (KiA) determined at various calcium concentrations with the three representative substrates
containing changes at the P2 position. ND, not determined.
CaCl2 (lM)
KiA (lM)
Abz-KARSSAQ-EDDnp Abz-KLRSSAQ-EDDnp Abz-KYRSSAQ-EDDnp
50 ND 2.9  0.1 6.4  0.3
100 ND 4.8  0.2 7.9  0.4
250 ND 12.3  0.6 9.4  0.4
500 ND 28.6  1.4 7.3  0.4
750 ND ND 10.9  0.5
1000 ND ND 14.7  0.6
2000 ND ND 11.0  0.5
5000 ND ND 12.4  0.6
A B C
Fig. 6. The effect of CaCl2 on the structure of TbMCA2. (A) Circular dichroism spectra of TbMCA2 in the absence (■) or in the presence (□)
of 1 mM CaCl2 or in the presence of 1 mM CaCl2 plus 10 mM EGTA (○). Ellipticity is reported as mean residue molar ellipticity Θ
(degcm2dmol1). (B) Fluorescence emission spectra of TbMCA2 (kex = 280 nm) in the absence (■) or in the presence (□) of 1 mM CaCl2 or
in the presence of 1 mM CaCl2 plus 10 mM EGTA (○). (C) Changes in the maximum fluorescence intensity at an emission wavelength of
330 nm upon increasing the CaCl2 concentration (log scale).
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peptidase activation was confirmed by visualizing the
autoprocessing products on SDS/PAGE (data not
shown). The far-UV circular dichroism spectra of
TbMCA2 in the absence and presence of 1 mM CaCl2
are shown in Fig. 6A and clearly show the secondary
structure modification in the presence of Ca2+. This
effect was completely reversed by subsequent addition
of 10 mM EGTA, indicating that TbMCA2 undergoes
a reversible structural change on binding Ca2+.
Intrinsic fluorescence emission spectra of TbMCA2
were measured in the absence of Ca2+ or in the pres-
ence of 10 mM EGTA, 0.1 mM CaCl2 or 1 mM CaCl2
(Fig. 6B). A shift in the intrinsic fluorescence of
TbMCA2 was observed in the presence of Ca2+,
which was more pronounced at higher Ca2+ concen-
trations (Fig. 6B). When the intrinsic fluorescence was
examined more closely and the shift in fluorescence
was plotted against a range of Ca2+ concentrations
(0–10 mM), the curve revealed two points of inflexion,
consistent with the existence of two Ca2+ binding sites
in TbMCA2 (Fig. 6C). Dissociation constants (KD) for
these two sites were calculated using the Adair equa-
tion giving KD1 = 3.0  0.3 lM and KD2 = 900 
100 lM. Data fitting could only be obtained using
n = 2 (two binding sites), confirming the visual obser-
vation of two points of inflexion.
Docking of VRPR into the active site of TbMCA2
Docking studies of VRPR into the active site of
TbMCA2, lacking five N-terminal residues, resulted in
the ligand binding in several conformations all of
which had similar predicted binding affinities. How-
ever, a 3D alignment of TbMCA2 with the structures
from other clan CD [2] members revealed that the
position of the catalytic dyad is conserved between all
structures in the family [17]. In addition, where these
structures have been determined with inhibitors bound
in their active sites (caspase-7, PDB ID 1F1J [24];
paracaspase, PDB ID 3UOA [20]; gingipain-R, PDB
ID 1CVR [25] and MARTX toxin, PDB ID 3GCD
[26]), the orientation of the ligand and the position of
the P1 residue are all consistent (data not shown).
Consequently, from the docking results, a conforma-
tion of VRPR in the active site of TbMCA2 was
chosen that bound to the enzyme in a similar manner
to other clan CD members.
VRPR docked into the crystal structure of TbMCA2
revealed that the P1 Arg of VRPR binds in the pre-
dicted, acidic S1 binding pocket of TbMCA2 with its
carbonyl oxygen situated between the catalytic dyad
(Fig. 7). It does this by forming hydrogen bonds, via
its guanidinium group, to the carboxylic acid groups
of Asp95 and Asp211 (Fig. 7A). Cys92 also sits within
hydrogen bonding distance of the functional group on
the P1 Arg (Fig. 7A) and the prime side of the bound
ligand sits at a narrow channel formed by His214 and
Thr160 (Fig. 7B).
The docked VRPR sits at a position previously
occupied by residues 31–34 (protein sequence YLVQ)
in the N-terminal domain of TbMCA2 (Fig. 7A).
These residues, along with residues at the C-terminal
end of the partially disordered 280-loop and on an
ordered loop between strand b1 and helix a1 in
TbMCA2 (residues 270–280 (sequence ATFGST
GSTGA) and 86–91 (sequence SAALSG), respectively
[17]), are the only areas of TbMCA2 that surround
the bound ligand and consequently are the most
likely to be involved in forming the S2–S3 binding
pockets.
A
B
Fig. 7. Docking of VRPR into the active site of TbMCA2C213G
lacking the N-terminal residues 31–35 (TbMCA2t). (A) Docked
VRPR interacts with residues in the S1 binding pocket (cyan) and
sits in the path of the deleted N-terminal region of TbMCA2 (blue).
(B) The docked P1 Arg of VRPR sits in the acidic S1 binding pocket
(including residues C92, D95, D211), sandwiched between the
catalytic dyad (C213G and H158) with the prime side of the ligand
situated near a narrow channel that includes residues H214 and
T160. The electrostatic surface potential of TbMCA2t was
calculated with APBS [42] contoured at  3 kT/e and shows the
positively (blue) and negatively (red) charged surface areas.
Structural figures were prepared using PYMOL [43].
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Discussion
Using a series of peptide substrates spanning the resi-
dues P3–P′3 of a TbMCA2 substrate, we have unequiv-
ocally demonstrated that TbMCA2 has a strict
preference for basic charged amino acids (Arg or Lys)
at the P1 position, with a preference for Arg. Similar
specificity occurs in metacaspases from other organ-
isms [8,13,23]. The 3D crystal structure of TbMCA2
revealed that the basis for this strict specificity results
from its S1 subsite being a negatively charged pocket
lined by the functional groups of residues Cys92,
Ser156, Asp95 and Asp211 [17]. To demonstrate how
a substrate with Arg at the P1 position might bind in
the S1 pocket of TbMCA2 we docked the peptide
VRPR into the active site of TbMCA2 (Fig. 7). This
revealed that the ligand bound to the active site
through its P1 Arg forming hydrogen bonds to Asp95
and Asp211 (Fig. 7B), which were previously shown to
be essential for TbMCA2 activity [17].
In addition to the clear specificity of TbMCA2 for
Arg or Lys in P1, it has also been shown that
TbMCA2 shows a preference for peptides containing
basic amino acids at the non-prime side (P2 and P3).
This was also shown for the P3 position for substrates
of Arabidopsis thaliana metacaspase 9 (AtMCA9)
where VRPR-AMC was identified as an optimized
substrate [27], and the kcat/KM values for TbMCA2
(Table 1) suggest that, from this series of peptides,
Abz- KKRSSA-EDDnp is one of the most effective
substrates for the enzyme. Furthermore, peptides con-
taining negatively charged residues Asp and Glu at
the P2 and P3 positions were resistant to hydrolysis by
TbMCA2. This result appears to be different in pro-
tein substrates, where autoprocessing in TbMCA2 was
found to occur at sites where Asp residues occupy the
P3 positions [9]. This is presumably due to the differ-
ences found in cleaving a large protein substrate as
opposed a small peptide, the character of which will
be dominated by the small number of residues present.
In addition, results from the docking studies of VRPR
into the active site of TbMCA2 suggest that the
regions most likely to form the S2 and S3 subsites are
reasonably hydrophobic but interspersed with several
polar residues (Ser, Thr and Gln). This suggests that,
even in the absence of highly acidic or basic func-
tional residues lining the S2 and S3 pockets of
TbMCA2, the enzyme specializes in, and has a prefer-
ence for, basic substrates and that negatively charged
residues, at least on a small peptide, will interfere with
its mechanism.
Peptides in our study containing non-basic residues
at P1 were found to be competitive inhibitors of
TbMCA2. As the S1 binding pocket has been shown
to be negatively charged (Fig. 7A and [17]) and is
almost certainly structured to be highly specific in
accepting basic P1 residues, it is most likely that these
peptides are involved in binding to an allosteric subsite
which subsequently prevents substrate binding to the
active site.
Substrate inhibition kinetics were also observed for
several other peptides in the series, perhaps most nota-
bly for substrates with aromatic residues (Phe and
Tyr) at positions P′1 and P′2. These peptides were resis-
tant to cleavage by TbMCA2 and their ability to func-
tion as competitive inhibitors suggests that aromatic
residues in these positions would also result in the sub-
strate being involved in an alternative mode of alloste-
ric binding. In addition, kinetic assays for the P′1
series suggested that the S′1 binding pocket may favour
residues with small side chains. This is also confirmed
by the maximum efficiency of TBMCA2, against this
series of FRET peptides, being achieved with the sub-
strate kcat/KM Abz- KARSIA–EDDnp. This can be
further explained by examining the position of the
prime side of the docked VRPR in the structure of
TbMCA2 (Fig. 7A) where a residue at this position
would sit near to the small groove in the protein that
would occlude larger aromatic side chains. In addition,
FRET peptides containing basic amino acids at the
prime side of the P1 Arg resulted in a second cleavage
site by TbMCA2, which meant that the resulting
kinetic parameters could not be calculated. However,
these additional cleavage sites were not observed in
assayed peptides that contained the P1 Arg along with
basic residues at positions P2 or P3. This shows that it
is important for TbMCA2 to form interactions in its
extended active site in order to execute substrate
hydrolysis.
TbMCA2 is dependent on Ca2+ for activation [9]
and the kinetic behaviour of TbMCA2 tested using
the entire series of FRET peptides revealed that the
concentration of Ca2+ had a differential effect on the
activity of TbMCA2 only when the series of peptides
that differed in P2 were used. In this series it was
found that both the type of residue at P2 and the
concentration of Ca2+ used could affect the activity
of TbMCA2 (Fig. 4, 5 and Table 2). These results
suggest that the substrate inhibition exhibited by these
peptides occurs in the vicinity of and/or via a Ca2+
binding site in TbMCA2 and that general allosteric
inhibition may occur by preventing Ca2+ binding to
the correct site(s) in the enzyme. In addition, the
change in the far-UV circular dichroism spectra of
TbMCA2 in the presence of 1 mM CaCl2
demonstrated that Ca2+ binding to the enzyme causes
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a reversible structural modification. These data were
backed up by intrinsic fluorescence assays, performed
in the presence of various Ca2+ concentrations, which
also indicated a structural shift on Ca2+ binding and
the presence of at least two Ca2+ binding sites in
TbMCA2. One of the binding sites was shown to have
a high affinity for Ca2+ (KD1 = 3.0  0.3 lM) while
the other had a much lower affinity (KD2 = 900 
100 lM).
Structural studies on (an inactive mutant of)
TbMCA2 identified a single Ca2+ binding site on the
surface of the protein (residues Asp173, Asp189,
Asp190 and Asp220), which was shown to be essential
for both the activity of the enzyme and inhibitor bind-
ing [17] and is assumed to be the high affinity Ca2+
binding site identified in this study. This site is found
at a location distinct from the active site and substrate
binding pocket of TbMCA2 and the available struc-
tural data suggest that Ca2+ binding this site would
not have a direct effect on the conformation of
TbMCA2. Despite a thorough search for Ca2+ bind-
ing sites in TbMCA2 crystals, none was identified.
However, TbMCA2 crystals that were soaked in vari-
ous concentrations of CaCl2 showed a large conforma-
tional change in a loop that is positioned near to the
predicted substrate binding pocket (denoted the 280-
loop) [17]. In the absence of bound substrate the 280-
loop was highly disordered in the crystal structures
and it is assumed that the low affinity Ca2+ binding
site and the conformational changes observed, using
far-UV circular dichroism and intrinsic fluorescence
emission spectra, can be attributed to movement in
this region.
In this study we have shown that peptides that are
resistant to cleavage can act as inhibitors of TbMCA2.
TbMCA2 has a highly specific P1 substrate binding
pocket and consequently the mechanism of inhibition
must be allosteric. In addition, certain substrates (e.g.
FRET substrates with Leu in P2) were found to inhibit
TbMCA2 at low concentrations of Ca2+ but not at
high, which suggests that the allosteric inhibition of
TbMCA2 is most likely to occur around the high
affinity Ca2+ binding site. In these cases, the substrate
is assumed to be binding to both the active and the
allosteric site at low Ca2+ concentrations and as the
concentration of Ca2+ increases the substrate is dis-
placed from the high affinity Ca2+ binding site allow-
ing the enzyme to retain full activity.
In another family of well-characterized calcium-
dependent proteases, the calpains, a two-stage activa-
tion mechanism is governed by two different types of
Ca2+ binding [28]. In view of our data, it seems
possible that a similar bi-modal Ca2+-dependent
mechanism could operate in TbMCA2. In the parasite,
TbMCA2 is found to reside mainly in the RAB11-
positive endosomes [7] where the basal level of Ca2+ is
reported to be ~ 100 nM [29]. This is 30 times lower
than the calculated KD1 (3.0  0.3 lM) leading to the
supposition that under regular conditions TbMCA2 is
inactive. This phenomenon was also observed in the
calpains where the levels of Ca2+ required to activate
the enzymes were much higher in vitro than those mea-
sured intracellular, leading to the hypothesis that cer-
tain cellular associations or events could lower the
Ca2+ activation threshold [30]. Consequently, we
assume that in vivo TbMCA2 will be activated in
response to certain cellular stimuli that will either raise
the Ca2+ levels or lower the Ca2+ activation threshold
in order to occupy both Ca2+ binding sites, and thus
intracellular Ca2+ levels will be used to control the
physiological function of MCA2 [9]. The Ca2+ depen-
dence of TbMCA2 (and presumably the other meta-
caspases) is key to unravelling the role of these
proteases.
Overall, this work has investigated the substrate
specificity of TbMCA2 from S3 to S′3 using a new ser-
ies of FRET substrates and the docking studies of
VRPR into the active site of the enzyme. As no in vivo
substrate for trypanosome MCA2 has been identified
to date, these studies provide insights into the proper-
ties of potential TbMCA2 substrates. They also dem-
onstrate the importance of the calcium ion for
TbMCA2 activity, revealing a reversible structural
modification on Ca2+ binding and the presence of a
high and low affinity binding site. Furthermore, this
work revealed that FRET peptides that were resistant
to hydrolysis by TbMCA2 acted as competitive inhibi-
tors and that substrates that differed in the P2 position
could produce differential Ca2+ effects on the activity
of TbMCA2, suggesting that the enzyme is susceptible
to allosteric inhibition via the high affinity Ca2+ bind-
ing site under certain conditions.
Experimental procedures
Expression of recombinant TbMCA2
The expression plasmid for recombinant TbMCA2 with an
N-terminal His-tag has been described previously [9]. This
plasmid was transformed into chemically competent Escheri-
chia coli BL21 (DE3) pLysS cells (Novagen, Darmstast,
Germany) and initially grown in 10 mL Luria broth med-
ium supplemented with kanamycin (50 lgmL1), chloram-
phenicol (50 lgmL1) and glucose (5 mM) (supplemented
LB, sLB) and incubated at 30 °C overnight (~ 16 h) with
shaking at 150 r.p.m. The overnight cultures were
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transferred to 1 L of sLB medium at 30 °C and grown
until the culture density reached an A600 of 0.4. The tem-
perature was reduced to 20 °C until the cell density reached
an A600 of 0.6–0.7 and the bacterial cells were then har-
vested by centrifugation (4000 g for 10 min at 4 °C).
Finally the cells were resuspended in 1 L of fresh sLB med-
ium (without glucose). At this point isopropyl-b-D-1-thioga-
lactopyranoside was added to a final concentration of
0.5 mM and the cells were incubated at 20 °C for 14–16 h
before being harvested by centrifugation at 4000 g for
10 min at 4 °C. The pellet was subsequently stored at
70 °C until required.
Purification of recombinant TbMCA2
The cell pellet was resuspended in 20 mL of 50 mM sodium
phosphate pH 8.0, 500 mM NaCl, 20 mM imidazole and
1 mgmL1 lysozyme and incubated on ice for 30 min
before the addition of 5 lgmL1 RNase, 5 lgmL1 DNase
and 0.02% Triton X-100. The solution was further incu-
bated for 30 min on ice before centrifugation at 26 000 g for
20 min at 4 °C and the supernatant was recovered.
The supernatant from the cell lysis was loaded onto a
1 mL HisTrap Ni2+ Sepharose column (GE Healthcare,
Amersham, UK) previously equilibrated in 20 mM sodium
phosphate pH 8.0, 500 mM NaCl (binding buffer) using a
flow rate of 0.5 mLmin1. The column was then washed
with 5 mL of binding buffer and recombinant TbMCA2
was purified and eluted using a step gradient consisting of
5 mL of 50, 100, 150 and 500 mM imidazole in the same buf-
fer. Recombinant TbMCA2 was found to elute between 100
and 150 mM imidazole (as confirmed by SDS/PAGE analy-
sis) and the fractions containing the protein were pooled. In
order to desalt and further purify the sample, the pooled
protein was loaded directly onto a Sephadex G-75
size-exclusion column, prepacked with 100 mL of resin
(GE Healthcare) and equilibrated in 50 mM Tris pH 7.4,
150 mM NaCl (NaCl/Tris buffer). Elution fractions were
analysed using SDS/PAGE and the fractions containing
recombinant TbMCA2 were collected. The fractions con-
taining pure, recombinant TbMCA2 were concentrated
(~ 10-fold) using an Amicon filtration unit (Millipore Corp.,
Billerica, MA, USA) equipped with a 10 kDa exclusion
membrane, and the recovered protein was stored in NaCl/
Tris buffer at 70 °C. The working aliquots were diluted in
NaCl/Tris buffer containing 30% glycerol and stored at
20 °C. Repeated freeze–thaw cycles can decrease TbMCA2
activity and were consequently avoided.
Peptide synthesis
FRET peptides of the type Abz-peptidyl-Gln-EDDnp,
where Abz is the fluorescent group ortho-aminobenzoic acid
and EDDnp is the C-terminal quencher moiety N-(2,4-dini-
trophenyl)-ethylenediamine, were synthesized by solid-phase
synthesis (as described in [31]) using a bench-top automated
solid-phase peptide synthesizer (PSSM-8, Shimadzu, Tokyo,
Japan). The molecular mass and purity of the peptides were
checked by analytical HPLC (Shimadzu 10AVP HPCL sys-
tem) and by MALDI-TOF MS using a microflex LT sys-
tem (Bruker Daltonics, Bremen, Germany). Stock solutions
of the peptide substrates were prepared in distilled water
and the concentration was measured spectrophotometrically
at 365 nm using the molar extinction coefficient of the Dnp
group of 17 300 M1cm1.
Kinetic assays
The activity of TbMCA2 was monitored by measuring the
release of fluorescent groups, Abz or AMC (7-amino-4-
methoxy coumarin), from the hydrolysis of the FRET sub-
strates Abz-peptidyl-Gln-EDDnp and benzyloxycarbonyl
(Z)-peptidyl-AMC respectively by the enzyme. Measure-
ments were made using a Shimadzu (Tokyo, Japan)
RF-5301PC spectrofluorometer with the excitation and
emission wavelengths set at 320 and 420 nm, respectively,
for the hydrolysis of the FRET substrates and 380 and
460 nm, respectively, for the hydrolysis of the Z-peptidyl-
AMC substrates.
A 1 cm path-length cuvette containing 1 mL of the sub-
strate solution was placed in a thermostatically controlled
cell compartment for 5 min before the enzyme solution was
added, and TbMCA2 was pre-incubated with 2.5 mM dith-
iothreitol. The kinetic measurements of peptide hydrolysis
were performed at 25 °C in 50 mM Tris/HCl pH 7.4, 100 mM
NaCl, 1 mM CaCl2, unless otherwise stated. The progress of
the reaction was continuously monitored by the fluorescence
of the released products. The rate of increase of fluorescence
was converted into moles of hydrolysed substrate per second,
based on the fluorescence curves of standard peptide solu-
tions before and after total enzymatic hydrolysis.
The enzyme concentration for the initial rate determina-
tion was chosen at a level intended to hydrolyse < 5% of
the substrate present. TbMCA2 concentrations varied from
1 nM to 100 nM and substrate concentrations were adjusted
in order to obtain a V 9 [S] plot with minimum substrate
concentration ranging from 0.1 KM to 10 KM. The inner fil-
ter effect was corrected for using an empirical equation
which has been described previously [32]. Kinetic parame-
ters (kcat, KM and kcat/KM) were calculated according to
Wilkinson [33] and by the use of Eadie–Hofstee plots.
The kinetic parameters for the peptides that presented
substrate inhibition kinetics were calculated using
V ¼ Vmax½S=fKM þ ½S=ð½S=KiAÞg (1)
where V is velocity, Vmax is the maximum velocity, [S] is
the substrate concentration, KM is the Michaelis constant
and KiA is the substrate inhibition constant.
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All of the data obtained were fitted to nonlinear least-
squares equations, using GRAFIT5 (Erithacus Software
[34]).
Determination of inhibition parameters
The substrate Abz-KARSSAQ-EDDnp was used as a ref-
erence substrate in the cleavage reactions with TbMCA2,
and any derivatives of this that were found to be resistant
to hydrolysis by TbMCA2 were assayed as competitive
inhibitors. For these peptides the inhibition parameters
were determined in a continuous assay using Z-FR-AMC
as the substrate. The equation used to calculate Ki values
was Ki = Ki,app/(1 + [S]/KM), where [S] is the molar con-
centration of the substrate, KM is the Michaelis constant
and Ki,app is the apparent inhibition constant. Ki,app was
calculated using the equation Vo/Vi = 1 + [I]/Ki,app, where
V0 is the velocity of hydrolysis without the inhibitor, Vi
is the velocity of hydrolysis in the presence of the inhibi-
tor and [I] is the molar concentration of the inhibitor. A
plot of (V0/Vi) – 1 versus [I] yields a slope of 1/Ki,app
[35].
The pH dependence of the kinetic parameters
The kcat/KM parameters were determined in the pH range
5–10 using Abz-KARSSAQ-EDDnp as the substrate in a
four-component buffer system of constant ionic strength
(25 mM glycine, 25 mM acetic acid, 25 mM MES and
75 mM Tris). The kinetic data were analysed by nonlinear
regression using GRAFIT5 software [34] and
k ¼ kðlimitÞ½1=ð1þ 10pK1pH þ 10pHpK2 Þ (2)
Equation (2) fits the data when the pH–activity profile
depends upon two ionizing groups in a bell-shaped curve
and the activities at low and high pH are zero. k(limit) cor-
responds to the pH-independent maximum rate constant,
K1 and K2 are the dissociation constants of a catalytically
competent base and acid, respectively, and k = kcat/KM
[35].
The effect of calcium on the intrinsic
fluorescence of TbMCA2
Structural changes in TbMCA2 were studied by monitoring
the intrinsic fluorescence in 50 mM Tris/HCl pH 7.4,
100 mM NaCl with the addition of varying concentrations
of CaCl2 (50 lM to 2 mM) and a final protein concentration
of 2 lM. The emission spectra were collected in the range
300–400 nm at 25 °C using a fixed excitation wavelength of
280 nm (2.5 nm slit width for both excitation and emis-
sion). These data were analysed using the Adair equation
that describes the binding of ligands to multiple sites on a
receptor using GRAFIT5 software [34].
Circular dichroism
Circular dichroism spectra were recorded on a JascoJ-810
spectropolarimeter (Jasco, Easton, MD, USA) with a Peltier
system for controlling cell temperature. The absorbance spec-
tra of TbMCA2 (10 lM) were collected in the far-UV range
(190–260 nm) using a 1 mm path-length cell. The system was
routinely calibrated with an aqueous solution of twice crystal-
lized d10-camphorsulfonic acid. Ellipticity was recorded as the
mean residue molar ellipticity Θ (degcm2dmol1). The spec-
trometer conditions typically included a sensitivity of 100
mdeg, a resolution of 0.5 nm, a response time of 4 s and a
scan rate of 20 nmmin1, and each curve is an average of four
sequential scans at 25 °C. The control baseline was obtained
with all buffer components prepared without the protein.
Protein concentration
For circular dichroism, intrinsic fluorescence and kinetic
assays the protein concentration was determined spectro-
photometrically based on the absorbance at 280 nm and on
the calculated molar extinction coefficient of 29 910
M
1cm1 (as calculated by PROTPARAM [36]).
Determination of cleavage sites in the substrates
The scissile bonds of hydrolysed peptide substrates were
identified by isolation of the fragments using analytical
HPLC followed by determination of their molecular mass
by liquid chromatography mass spectrometry using an
LCMS-2010 EV mass spectrometer (Shimadzu) equipped
with an electrospray ionization probe. For the substrates
hydrolysed at two sites the percentage of each cleavage
product was calculated from the individual integrated areas
taken from the chromatograms.
Protein docking studies
A protein model of TbMCA2 was prepared by taking a
structure from the Protein Data Bank (PDB [37]; PDB ID
4AF8 [17]) and removing all heteroatoms, including water
molecules, and N-terminal residues 31–35 inclusive. Hydro-
gen atoms were added to this model and a 3D grid was
designed with the predicted S1 binding site [17] at the cen-
tre, in order to facilitate receptor docking, using AUTODOCK-
TOOLS4 [38].
The peptide inhibitor benzoxycarbonyl-Val-Arg-Pro-Arg-
fluoromethylketone (Z-VRPR-FMK) has been shown to be
an inhibitor of TbMCA2 [17] and was consequently chosen
as the ligand for docking studies. The 3D structure of
VRPR was taken from the crystal structure of a mamma-
lian paracaspase [20] and AUTODOCKTOOLS4 was used to
assign flexible torsions, Gasteiger charges and nonpolar
hydrogen atoms. Docking of the ligand into the prepared
structure of TbMCA2 was then carried out using AUTODOCK
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VINA [39]. All 3D structural alignments were carried out
using SSM SUPERPOSE [40] and COOT [41].
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